Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "Malaria"

ResearchBIORXIVMar 26

Preprint: Discovery of Plasmodium falciparum SR12 as a GOLD-Domain seven transmembrane protein regulating GPCR trafficking in mammalian cells

Scientists discovered a new protein called SR12 in the malaria parasite that works similarly to proteins in human cells. This protein might be a good target for creating new malaria drugs, especially since the parasite is becoming resistant to current treatments. The researchers used computer modeling to understand how this protein is structured and how it functions.

WHY IT MATTERSThis research could lead to new antimalarial drugs that work differently than current ones, which is critical because malaria parasites are increasingly resistant to existing treatments and malaria still kills hundreds of thousands of people annually.
Good to knowmalariaRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases